Meena Gorowara
HIV Netherlands Australia Thailand Research Collaboration(TH)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV-related health complications and treatments, HIV/AIDS Research and Interventions, Pharmacological Effects and Toxicity Studies
Most-Cited Works
- → Pharmacokinetics and 48-Week Efficacy of Nevirapine: 400 mg Versus 600 mg per day in HIV–Tuberculosis Coinfection Receiving Rifampicin(2008)51 cited
- → Efavirenz, in Contrast to Nevirapine, is Associated With Unfavorable Progesterone and Antiretroviral Levels When Coadministered With Combined Oral Contraceptives(2012)42 cited
- → A Low Dose of Ritonavir-Boosted Atazanavir Provides Adequate Pharmacokinetic Parameters in HIV-1-Infected Thai Adults(2008)35 cited
- → Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals(2008)23 cited
- → Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children(2009)21 cited
- → Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy(2011)21 cited
- → Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maintenance Therapy(2012)15 cited
- → Short Communication: Aging Not Gender Is Associated with High Atazanavir Plasma Concentrations in Asian HIV-Infected Patients(2013)11 cited
- → Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries(2009)11 cited
- → THERAPEUTIC DRUG MONITORING OF LOPINAVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN RECEIVING ADULT TABLETS(2009)11 cited